View profile

Drones disinfect hotspots in India; Fourier Intelligence raises $14.11m

Revue
 
Good morning, Here's your Monday edition of Asia AI News! Shanghai-based Fourier Intelligence announc
 
May 11 · Issue #240 · View online
Asia AI News
Good morning,
Here’s your Monday edition of Asia AI News!
Shanghai-based Fourier Intelligence announced a successful Series B round last summer and according to this week’s news it has extended fund raising to a B+ round netting $14 million.
Meanwhile, despite a country-wide lockdown and an impressive array of emerging technology applications employed to fight Covid-19, director of China’s National Health Commission Li Bin admits that the outbreak exposed weaknesses in China’s health system.
Scroll down for these stories and more.
Have a good week and stay safe!
/Carrington

Startup News
Fourier Intelligence raises $14.11 million Series B and Series B + Fourier Intelligence raises $14.11 million Series B and Series B +
Markets
China's Kingsoft sees stock pop in U.S. market debut
Education
Global users of Chinese learning platform exceed half million
IIT Roorkee launches online course on AI, deep learning
R&D
China promotes local AI pilot zones
Coronavirus
India uses drones to disinfect virus hotspot as cases surge India uses drones to disinfect virus hotspot as cases surge
COVID-19 and the advent of a 'contactless economic system'
Boston Dynamics’ Spot is patrolling a Singapore park to encourage social distancing
‘Corona combat drone’ with thermal cameras, disinfectant being tested In India
AI-based system to check mask violations
How drones could change the future of healthcare delivery
Geopolitics
Chinese official admits health system weaknesses Chinese official admits health system weaknesses
Shutting Chinese out of US universities could hurt America more than China
Follow Asia AI News on Twitter
Read Friday’s Asia AI News
Did you enjoy this issue?
If you don't want these updates anymore, please unsubscribe here.
If you were forwarded this newsletter and you like it, you can subscribe here.
Powered by Revue